Critical management in patients with severe enterovirus 71 infection

Jieh-Neng Wang1, Chih-Ta Yao, Cheng-Nan Yeh

  • 1Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Insights

Early cardiopulmonary support and milrinone improve outcomes in severe enterovirus 71 (EV71) infection. This critical care strategy enhances survival rates in pediatric patients with EV71.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Virology

Background:

  • Severe enterovirus 71 (EV71) infection poses a significant threat to children.
  • Effective critical care strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To analyze clinical details of severe EV71 infection in children.
  • To synthesize critical care experience for managing severe EV71 infection.

Main Methods:

  • Retrospective analysis of pediatric patients with severe EV71 infection.
  • Comparison of a control group (March 1998-April 2000) with a study group receiving protocol therapy (May 2000-March 2003).
  • Detailed collection of clinical and pharmacological data for comparison.

Main Results:

  • No significant difference in clinical presentations or laboratory findings between groups.
  • Lower intravenous fluid administration in the study group (4.9 vs 9.2 mL/kg per h).
  • Higher survival rates in the study group (100% acute, 87% long-term) compared to the control group (43% acute, 29% long-term).
  • Specific pharmacological interventions differed: more dopamine and less epinephrine in the study group; milrinone used in the study group.

Conclusions:

  • Early cardiopulmonary support is vital to prevent cardiopulmonary failure and improve outcomes in severe EV71 infection.
  • Milrinone appears to be an effective inotropic agent for these patients.
  • Echocardiography, central lines, and arterial lines can guide management, potentially replacing direct intracardiac monitoring.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...